Gilead prepares for anticipated hep C drug approval with plant expansion

Carly Helfand

If the FDA takes the recommendation from a panel that voted 15-0 last week to approve hep C treatment sofosbuvir, maker will be ready.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS